Log in

Relevant bibliographies by topics / Gammapathie biclonale

Contents

Journal articles
Dissertations / Theses

Academic literature on the topic 'Gammapathie biclonale'

Author: Grafiati

Published: 4 June 2021

Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Gammapathie biclonale.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Gammapathie biclonale"

1

Hicham, Eddou, Zinebi Ali, Abbadi Abderrahim, et al. "Gammapathie biclonale révélant un myélome multiple chez un patient suivi pour une leucémie lymphoïde chronique." Revue Francophone des Laboratoires 2017, no. 495 (2017): 64–67. http://dx.doi.org/10.1016/s1773-035x(17)30325-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Leroy, H., O. Decaux, J. C. Ianotto, et al. "Caractéristiques cliniques et biologiques des gammapathies biclonales. Description d’une cohorte de 203 patients." La Revue de Médecine Interne 29 (December 2008): S320. http://dx.doi.org/10.1016/j.revmed.2008.10.089.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Decaux, Olivier, Helene Leroy, Jean-Christophe Ianotto, et al. "Clinical and Biological Features of Biclonal Gammopathies. Review of 203 Cases." Blood 112, no. 11 (2008): 5151. http://dx.doi.org/10.1182/blood.v112.11.5151.5151.

Full text

Abstract:

Abstract Introduction: Biclonal gammopathies represent about 5% of clonal gammopathies. We describe the clinical and laboratory features of biclonal gammopathies identified in a French university hospital. Methods: Patients were selected by immunofixation registry of Biochemistry laboratory. Results: From 1987 to 2008, 203 biclonal gammapathies were identified. Patients were 113 men and 90 women. Median age was 72.0 years (35–95). Seventy eight patients (38.3%) had IgG and IgM components, 64 (31,9%) had two IgG, 24 (11,8%) had IgG and IgA, 23 (11,3%) had two IgM, 8 (3,9%) had IgM and IgA, 5 (2

APA, Harvard, Vancouver, ISO, and other styles

4

Decaux, Olivier, Sophie Besnard, Antoinette Perlat, et al. "Regular Follow-Up of MGUS Allow Early Detection of Malignant Transformation Before Severe Complications Occur." Blood 110, no. 11 (2007): 4774. http://dx.doi.org/10.1182/blood.v110.11.4774.4774.

Full text

Abstract:

Abstract Background: Monoclonal gammapathy of unknown significance (MGUS) is a frequent disorder that carries a 1% per year risk of progression to multiple myeloma (MM). Patients should be monitored annually to detect malignant transformation before complications occur. Objective: To assess if MGUS regular follow-up allow early detection of malignant transformation before severe complications occur. Progression to multiple myeloma was established according to the criteria defined by the International Working Group. Criteria for severe complication were: hypercalcemia (> 3 mmol/l), acute ren

APA, Harvard, Vancouver, ISO, and other styles

5

Palladini, Giovanni, Tiziana Bosoni, Paolo Milani, et al. "Use of the Novel Monoclonal Assay for the Measurement of Circulating Free Light Chain in the Diagnosis, Prognostication of Survival and Assessment of Response to Therapy in AL Amyloidosis." Blood 120, no. 21 (2012): 3913. http://dx.doi.org/10.1182/blood.v120.21.3913.3913.

Full text

Abstract:

Abstract Abstract 3913 The possibility of measuring the circulating free light chains (FLC) improved our ability to detect the amyloidogenic clone, allowed refined risk stratification in combination with cardiac biomarkers, and provided a formidable tool for assessing response to treatment in AL amyloidosis. Recently, a novel method for FLC quantitation based on monoclonal antibodies has been developed. We evaluated its performance in the diagnosis, prognostication of survival, and response assessment in 353 consecutive newly diagnosed patients with AL amyloidosis enrolled between 2007 and 201

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Gammapathie biclonale"

1

DUCASSE, OLIVIER. "Les gammapathies biclonales : etude biologique et correlation clinique ; a propos de 64 observations." Nantes, 1991. http://www.theses.fr/1991NANT062M.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!